Researchers have identified inconsistent beliefs among medical specialists as to who is responsible for ordering tumor microsatellite instability and immunohistochemistry tests for Lynch syndrome.
Jordan J. Karlitz, MD, director of the GI Hereditary Cancer and Genetics Program at Tulane University School of Medicine, and colleagues distributed a 21-question web-based survey to physicians on the ACG email listserv, to identify opinions and barriers experienced by gastroenterologists involving screening tests for Lynch syndrome.
The survey was completed by 509 physicians, 442 confirmed

Source link